Overview

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to test for bioequivalence between two formulations of Insulatard® in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human